To study the clinical application effect of interventional embolization for the treatment of infertility caused by hydrosalpinx.

A total of 299 patients with hydrosalpinx admitted to the Dalian Women and Children Medical Center from October 2016 to October 2018 were enrolled. Among them, 169 patients underwent interventional embolization for study group A and 91 patients underwent routine surgery (laparoscopic surgery) . Patients with tubal stoma or resection were studied in group B, and 39 untreated patients were in the control group. The ovarian function of anti-Mullerian hormone (AMH) , implantation rate and ectopic pregnancy rate were compared between the three groups.

There was no significant difference in AMH between the three groups before operation (P>0.05) . After operation, the AMH level in group A was higher than that in group B [ (3.09±1.73) ng/ml vs. (2.69±2.03) ng/ml], the difference was statistically significant (P=0.011) , and the AMH level in the study group A was higher than that before surgery [ (3.09±1.73) ng/ml vs. (2.30±1.21) ng/ml], the difference was statistically significant. The implantation rate of the study group A was 42.6%, which was significantly higher than that of the study group B (29.6%) and the control group (10.2%) . The ectopic pregnancy rate of the study group A was 1.8%, which was lower than that of the study group B (3.3%) . There was a statistically significant difference between the control group and the control group (2.6%) (P<0.05) .

Interventional embolization for the treatment of hydrosalpinx, ovarian function is not affected, the implantation rate is higher, the ectopic pregnancy rate is lower, the operation technology is reliable, and it is worthy of clinical application.